Pre- and post-transplantation risk factors for delirium onset and severity in patients undergoing hematopoietic stem-cell transplantation

Journal of Clinical Oncology

Volumn 29, Issue 7, 2011, Pages 895-901

  Fann, Jesse R ^a   Hubbard, Rebecca A ^a   Alfano, Catherine M ^a   Roth Roemer, Sari ^a   Katon, Wayne J ^a   Syrjala, Karen L ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CYCLOSPORIN; LORAZEPAM; MORPHINE; PREDNISONE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BREAST CARCINOMA; CHRONIC MYELOID LEUKEMIA; CLINICAL ASSESSMENT; CORTICOSTEROID THERAPY; DELIRIUM; DISEASE SEVERITY; FEMALE; GRAFT VERSUS HOST REACTION; HAZARD RATIO; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; MULTIVARIATE ANALYSIS; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; OVARY CARCINOMA; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RATING SCALE; RISK ASSESSMENT; RISK FACTOR; SELF REPORT; SENSITIVITY ANALYSIS; UREA NITROGEN BLOOD LEVEL; VALIDATION STUDY;

ADULT; AGE DISTRIBUTION; BLOOD CHEMICAL ANALYSIS; COHORT STUDIES; DELIRIUM; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POSTOPERATIVE CARE; PREOPERATIVE CARE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SURVIVAL RATE; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79952294305     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.28.4521     Document Type: Article

References (50)

1. Fann JR, Roth-Roemer S, Burington BE, et al: Delirium in patients undergoing hematopoietic stem cell transplantation. Cancer 95:1971-1981, 2002
2. Caraceni A, Nanni O, Maltoni M, et al: Impact of delirium on the short term prognosis of advanced cancer patients: Italian Multicenter Study Group on Palliative Care. Cancer 89:1145-1149, 2000
3. Coyle N, Breitbart W, Weaver S, et al: Delirium as a contributing factor to "crescendo" pain: Three case reports. J Pain Symptom Manage 9:44-47, 1994
4. Gagnon B, Lawlor PG, Mancini IL, et al: The impact of delirium on the circadian distribution of breakthrough analgesia in advanced cancer patients. J Pain Symptom Manage 22:826-833, 2001 (Pubitemid 32884375)
5. Tuma R, DeAngelis LM: Altered mental status in patients with cancer. Arch Neurol 57:1727-1731, 2000
6. Ljubisavljevic V, Kelly B: Risk factors for development of delirium among oncology patients. Gen Hosp Psychiatry 25:345-352, 2003 (Pubitemid 37102942)
7. Breitbart W, Gibson C, Tremblay A: The delirium experience: Delirium recall and delirium-related distress in hospitalized patients with cancer, their spouses/caregivers, and their nurses. Psychosomatics 43:183-194, 2002 (Pubitemid 34522528)
8. Hallberg IR: Impact of delirium on professionals. Dement Geriatr Cogn Disord 10:420-425, 1999
9. Bruera E, Bush SH, Willey J, et al: Impact of delirium and recall on the level of distress in patients with advanced cancer and their family caregivers. Cancer 115:2004-2012, 2009
10. Lawlor PG, Gagnon B, Mancini IL, et al: Occurrence, causes, and outcome of delirium in patients with advanced cancer: A prospective study. Arch Intern Med 160:786-794, 2000 (Pubitemid 30165239)
11. Beglinger LJ, Duff K, Van Der Heiden S, et al: Incidence of delirium and associated mortality in hematopoietic stem cell transplantation patients. Biol Blood Marrow Transplant 12:928-935, 2006
12. Fann JR, Alfano CM, Roth-Roemer S, et al: Impact of delirium on cognition, distress, and health-related quality of life after hematopoietic stem-cell transplantation. J Clin Oncol 25:1223-1231, 2007 (Pubitemid 46640568)
13. Basinski JR, Alfano CM, Katon WJ, et al: Impact of delirium on distress, health-related quality of life, and cognition 6 months and 1 year after hematopoietic cell transplant. Biol Blood Marrow Transplant 16:824-831, 2010
14. Siddiqi N, Stockdale R, Britton AM, et al: Interventions for preventing delirium in hospitalised patients. Cochrane Database Syst Rev 2:CD005563, 2007
15. Levy M, Fann J: The neuropsychiatry of hematopoietic stem cell transplantation. Eur J Psychiat 20:107-128, 2006 (Pubitemid 44526421)
16. Yoshimura Y, Kubo S, Shirata K, et al: Risk factors for postoperative delirium after liver resection for hepatocellular carcinoma. World J Surg 28:982-986, 2004 (Pubitemid 40109881)
17. Fann JR, Sullivan AK: Delirium in the course of cancer treatment. Semin Clin Neuropsychiatry 8:217-228, 2003 (Pubitemid 37474732)
18. Doriath V, Paesmans M, Catteau G, et al: Acute confusion in patients with systemic cancer. J Neurooncol 83:285-289, 2007 (Pubitemid 46952240)
19. Morita T, Tei Y, Tsunoda J, et al: Underlying pathologies and their associations with clinical features in terminal delirium of cancer patients. J Pain Symptom Manage 22:997-1006, 2001 (Pubitemid 33152685)
20. Dunlop RJ, Campbell CW: Cytokines and advanced cancer. J Pain Symptom Manage 20:214-232, 2000
21. Gaudreau JD, Gagnon P, Harel F, et al: Psychoactive medications and risk of delirium in hospitalized cancer patients. J Clin Oncol 23:6712-6718, 2005 (Pubitemid 46190266)
22. Gaudreau JD, Gagnon P, Roy MA, et al: Opioid medications and longitudinal risk of delirium in hospitalized cancer patients. Cancer 109:2365-2373, 2007 (Pubitemid 46801569)
23. Trzepacz PT, Baker RW, Greenhouse J: A symptom rating scale for delirium. Psychiatry Res 23:89-97, 1988
24. Trzepacz PT: The Delirium Rating Scale: Its use in consultation-liaison research. Psychosomatics 40:193-204, 1999
25. Breitbart W, Rosenfeld B, Roth A, et al: The Memorial Delirium Assessment Scale. J Pain Symptom Manage 13:128-137, 1997 (Pubitemid 27172870)
26. Lawlor PG, Nekolaichuk C, Gagnon B, et al: Clinical utility, factor analysis, and further validation of the Memorial Delirium Assessment Scale in patients with advanced cancer: Assessing delirium in advanced cancer. Cancer 88:2859-2867, 2000 (Pubitemid 30417951)
27. Grassi L, Caraceni A, Beltrami E, et al: Assessing delirium in cancer patients: The Italian versions of the Delirium Rating Scale and the Memorial Delirium Assessment Scale. J Pain Symptom Manage 21:59-68, 2001 (Pubitemid 32149664)
28. Reitan RM, Wolfson D: The Halstead-Reitan Neuropsychological Test Battery: Theory and Clinical Interpretation. Tuscan, AZ, Neuropsychology Press, 1993
29. Ware J Jr, Kosinski M, Keller SD: A 12-Item Short-Form Health Survey: Construction of scales and preliminary tests of reliability and validity. Med Care 34:220-233, 1996 (Pubitemid 126433231)
30. Wolters Kluwer Health: Facts and Comparisons 4.0. http://online. factsandcomparisons.com/index.aspx?
31. Labbate L, Fava M, Rosenbaum J, et al: Handbook of Psychiatric Drug Therapy (ed 6). New York, NY, Lippincott Williams & Wilkins, 2009
32. Carnahan RM, Lund BC, Perry PJ, et al: The Anticholinergic Drug Scale as a measure of drugrelated anticholinergic burden: Associations with serum anticholinergic activity. J Clin Pharmacol 46:1481-1486, 2006 (Pubitemid 44704208)
33. Przepiorka D, Weisdorf D, Martin P, et al: 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 15:825-828, 1995
34. Cox DR: Regression models and life tables. J R Stat Soc B 34:187-220, 1972
35. Harrell F, Harrell F: Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis. New York, NY, Springer, 2001
36. Pepe M: The Statistical Evaluation of Medical Tests for Classification and Prediction. New York, NY, Oxford University Press, 2004
37. Harrell FE Jr, Lee KL, Mark DB: Multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15:361-387, 1996 (Pubitemid 26072233)
38. Little R, Rubin D: Statistical Analysis With Missing Data (ed 2). New York, NY, Wiley & Sons, 2002
39. R Development Core Team: A language and environment for statistical computing. http://www.R-project.org
40. Bensinger WI, Martin PJ, Storer B, et al: Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med 344:175-181, 2001 (Pubitemid 32064138)
41. Sagawa R, Akechi T, Okuyama T, et al: Etiologies of delirium and their relationship to reversibility and motor subtype in cancer patients. Jpn J Clin Oncol 39:175-182, 2009
42. Han L, McCusker J, Cole M, et al: Use of medications with anticholinergic effect predicts clinical severity of delirium symptoms in older medical inpatients. Arch Intern Med 161:1099-1105, 2001 (Pubitemid 32685536)
43. Tune L, Carr S, Cooper T, et al: Association of anticholinergic activity of prescribed medications with postoperative delirium. J Neuropsychiatry Clin Neurosci 5:208-210, 1993 (Pubitemid 23154534)
44. Fann JR, Alfano CM, Burington BE, et al: Clinical presentation of delirium in patients undergoing hematopoietic stem cell transplantation. Cancer 103:810-820, 2005 (Pubitemid 40216411)
45. Inouye SK, Charpentier PA: Precipitating factors for delirium in hospitalized elderly persons: Predictive model and interrelationship with baseline vulnerability. JAMA 275:852-857, 1996 (Pubitemid 26087222)
46. Syrjala KL, Cummings C, Donaldson GW: Hypnosis or cognitive behavioral training for the reduction of pain and nausea during cancer treatment: A controlled clinical trial. Pain 48:137-146, 1992
47. Syrjala KL, Donaldson GW, Davis MW, et al: Relaxation and imagery and cognitive-behavioral training reduce pain during cancer treatment: A controlled clinical trial. Pain 63:189-198, 1995
48. Marcantonio E, Ta T, Duthie E, et al: Delirium severity and psychomotor types: Their relationship with outcomes after hip fracture repair. J Am Geriatr Soc 50:850-857, 2002 (Pubitemid 34496681)
49. Bruera E, Franco JJ, Maltoni M, et al: Changing pattern of agitated impaired mental status in patients with advanced cancer: Association with cognitive monitoring, hydration, and opioid rotation. J Pain Symptom Manage 10:287-291, 1995
50. Donner A: Some aspects of the design and analysis of cluster randomization trials. J R Stat Soc C 47:95-113, 1998